Approved Projects
Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.
Name | Principal Investigator | Institution | Study | Date Approved | Project ID |
---|---|---|---|---|---|
Genetic determinants of liver cancer | Sonja Berndt | National Cancer Institute | PLCO | Feb 5, 2024 | PLCO-1467 |
Development and Validation of Early Detection Biomarkers for Liver Cancer | Xuehong Zhang | Yale University | PLCO | Jan 30, 2024 | 2023-0085 |
Spatial Interplay of Tumor-Infiltrating Lymphocytes and Cancer Cells Identify Low-Risk Patients with Favorable Prognosis across Multiple Gastrointestinal Cancers | Anant Madabhushi | Emory University | PLCO | Jan 30, 2024 | PLCOI-1468 |
Microsimulation model of a risk-based lung cancer screening program | Jacopo Di Silvestre | University of Oslo | NLST | Jan 26, 2024 | NLST-1191 |
Early Detection and Personalized Treatment of Colon Cancer: Integrating Genetic, Demographic, and Lifestyle Data | JULIET KURUVILLA | HOWARD UNIVERSITY | PLCO | Jan 26, 2024 | PLCO-1460 |
A study using AI methods to examine the effects of malnutrition on cancer patients' life expectancies | Shaesta Mujawar | P. G. Department of Computer Science, S.N.D.T. Women's University | PLCO | Jan 26, 2024 | PLCO-1455 |
Evolution of cancer stage and mortality in the PLCO trial (NCI Version) | Eric Miller | NCI | PLCO | Jan 22, 2024 | PLCO-1462 |
Time course of biomarkers | Paul Pinsky | DCP, NCI | PLCO | Jan 18, 2024 | PLCO-1454 |
Lung disease detection using CT scan and AI | Vaibhav Ram | SRM institute of science and technology | NLST | Jan 17, 2024 | NLST-1190 |
Predicting Prostate cancer Tissue type with machine learning | Md. Salman Karim Khan | Chittagong Medical College | PLCO | Jan 17, 2024 | PLCO-1450 |
Lung Cancer Risk Analysis | Danbir Rashid | Leading University | NLST | Jan 16, 2024 | NLST-1187 |
Lung Cancer Risk Analysis | Danbir Rashid | Leading University | PLCO | Jan 16, 2024 | PLCO-1447 |
Ovarian Cancer Classification | Lakshmi kumari | Puducherry Technological University | PLCO | Jan 16, 2024 | PLCO-1443 |
Cancer risk assessment by GAGome - a noninvasive biomarker for risk-stratified multi-cancer early detection | Volker Liebenberg | Elypta AB | PLCO | Jan 16, 2024 | 2023-0081 |
The Practical Application of the Lung Cancer Risk Prediction Model 'Sybil': Replicating and Validating Study Results in Taiwan | Tsung-Ren Huang | National Taiwan University | NLST | Jan 11, 2024 | NLST-1186 |
A Deep Learning Approach for Prostate Cancer Screening | Julio Cesar Gali | Pontifícia Universidade Católica de São Paulo | PLCO | Jan 11, 2024 | PLCO-1440 |
Validation of proteomic assay for early detection of pancreatic cancer using PLCO pre-diagnostic specimens | Ru Chen | Baylor College of Medicine | PLCO | Jan 11, 2024 | 2023-0088 |
AI-based prognosis and therapy response prediction from pathology images | Iurii Tolkach | Institute of Pathology, University Hospital Cologne | PLCO | Jan 9, 2024 | PLCOI-1441 |
Pan-cancer digital pathology AI foundation model and its application in cancer prognostication | Jan Witowski | Ataraxis AI, Inc. | PLCO | Jan 9, 2024 | PLCOI-1433 |
Risk prediction of prostate cancer mortality in a screening cohort. | Patrick Lewicki | University of Michigan | PLCO | Jan 9, 2024 | PLCO-1439 |